Sirolimus-Associated Infertility: Case Report and Literature Review of Possible Mechanisms
Article first published online: 31 AUG 2007
DOI: 10.1111/j.1600-6143.2007.01929.x
Additional Information
How to Cite
Deutsch, M. A., Kaczmarek, I., Huber, S., Schmauss, D., Beiras-Fernandez, A., Schmoeckel, M., Ochsenkuehn, R., Meiser, B., Mueller-Hoecker, J. and Bruno Reichart, B. (2007), Sirolimus-Associated Infertility: Case Report and Literature Review of Possible Mechanisms. American Journal of Transplantation, 7: 2414–2421. doi: 10.1111/j.1600-6143.2007.01929.x
Publication History
- Issue published online: 31 AUG 2007
- Article first published online: 31 AUG 2007
- Received 13 March 2007, revised 05 June 2007 and accepted for publication 28 June 2007
Vol. 8, Issue 2, 472–476, Article first published online: 7 JAN 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- Heart transplantation;
- immunosuppression;
- oligospermia;
- sirolimus;
- tertiality
The authors delineate a case of sirolimus-associated infertility and provide a detailed synopsis of potential molecular mechanisms by which the mTOR-inhibitor sirolimus may negatively influence spermatogenesis.
The mammalian-target-of-rapamycin/mTOR-inhibitor sirolimus as a component of the immunosuppressive strategy after solid organ transplantation is effective at preventing allograft rejection. However, recent reports indicate that sirolimus is associated with altered sex hormone levels and impaired sperm quality parameters.
Herein, we report on a case of sirolimus-associated infertility in a young male heart-lung transplant recipient and provide a detailed synopsis of potential mechanisms by which sirolimus may negatively influence spermatogenesis. Testicular immunohistochemistry, the course of sex hormone and sperm quality parameters of our patient support the hypothesis that mTOR might act as an important key regulator in the reproductive system. Fortunately, due to withdrawal of sirolimus as part of the maintenance, immunosuppression improved sperm quality and sex hormone parameters could be observed. Recently, these improvements even resulted in a spontaneous pregnancy of the patient's wife more than 1 year after the drug was withdrawn. In our view, oligospermia as a possible and at least partly reversible side-effect of mTOR inhibitors has to be taken into consideration, particularly, when administrated to young male patients.

1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)
